Correlation Between Korean Drug and SDN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Korean Drug and SDN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and SDN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korean Drug Co and SDN Company, you can compare the effects of market volatilities on Korean Drug and SDN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of SDN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and SDN.

Diversification Opportunities for Korean Drug and SDN

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Korean and SDN is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and SDN Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SDN Company and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with SDN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SDN Company has no effect on the direction of Korean Drug i.e., Korean Drug and SDN go up and down completely randomly.

Pair Corralation between Korean Drug and SDN

Assuming the 90 days trading horizon Korean Drug Co is expected to under-perform the SDN. But the stock apears to be less risky and, when comparing its historical volatility, Korean Drug Co is 2.27 times less risky than SDN. The stock trades about -0.05 of its potential returns per unit of risk. The SDN Company is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  174,500  in SDN Company on September 14, 2024 and sell it today you would lose (44,800) from holding SDN Company or give up 25.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Korean Drug Co  vs.  SDN Company

 Performance 
       Timeline  
Korean Drug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
SDN Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SDN Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Korean Drug and SDN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Korean Drug and SDN

The main advantage of trading using opposite Korean Drug and SDN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, SDN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SDN will offset losses from the drop in SDN's long position.
The idea behind Korean Drug Co and SDN Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk